Dubai PR Network, Online Press Release from Dubai and Middle East
 
Recruitment & Jobs(Others)
Filter PR by
  
It's time for the Pharmaceutical industry to redefine the emerging markets says Booz & Company's latest study
 

•    One in every two top pharma company managers expects share of revenues coming from emerging markets to exceed 30% by 2018
•    We have started witnessing an influx of global pharma manufactures focusing on optimizing their regional (Middle East) operations and setting up joint ventures and with regional public and private sector players, this will surely impact the sector positively
•    To complement the increased influx of global pharma manufacturers we have witnessed a number of encouraging initiatives from different GCC governments to encourage private sector participation in the sector
               
Dubai, UAE, April 8, 2013- International pharmaceutical companies expect a significant rise in business activity in emerging markets over the next five years. The statement is one of the key findings in a recent research report by the international strategy consulting firm Booz & Company who interviewed executives from more than 25 of the top pharmaceutical companies, together covering some 50% of the total pharmaceutical revenues. 52% of the top managers who took part in the survey claim that, by 2018, more than 30% of their respective companies' revenue will come from emerging markets. Today, the threshold is only 23%, equating to $191bn of revenue in emerging markets. Nevertheless, companies should be aware that whilst there is huge potential here, variations within the emerging markets themselves, require different and tailored approaches. 

“The BRICMT-countries (Brazil, Russia, India, China, Mexico and Turkey) have become a viable alternative to Europe and the USA. In the non-established markets, pharma companies have a unique opportunity to enter early and shape the market,” said Stephan Danner, Partner with Booz & Company's Health practice. The emerging markets have long been regarded as the “promised land” of the pharmaceutical industry, yet, so far, ambitious targets remain unachieved.

To effectively serve these markets, there is a change in thinking in the boardrooms: a greater proportion of operations will need to be bespoke to individual markets to adapt to local idiosyncrasies. Indeed, 27% of those surveyed see current strategies insufficiently tailored to local market conditions to be the biggest failing. One of the executives interviewed said, “one of our biggest mistakes was to treat emerging markets like mature markets. We were wrong. Pharmaceutical strategies have to fit a country's individual needs and development.” The findings of the study firmly point to localisation being the most effective way of driving growth in the emerging markets. Thus, 77% of survey participants deemed the deployment of local operational teams in BRICMT markets to be a sensible move. 67% have voiced their support for a local production unit, and 65% support the creation of a local R&D division. These views are well supported by investment foundations:  78% are planning further expansion of local offices in BRICMT – a sign of the degree of trust companies have in the stability of these countries. 'We have started witnessing an influx of global pharma manufactures focusing on optimizing their regional (Middle East) operations and setting up joint ventures and with regional public and private sector players, this will surely impact the sector positively' confirmed Gabriel Chahine, the partner leading the Healthcare practice at Booz & Company in the Middle East.

The adaptation to new market dynamics is expected to occur swiftly: in a matter of 5 to 10 years, 67% expect the Marketing & Sales functions within BRICMT countries to closely resemble those in established markets. This has clear consequences for the classical operating model of companies: the majority of interviewees expect that the weight of responsibility and ownership will gradually shift from the central HQs to regional subsidiaries; however challenges such as recruiting suitable local talents remain a large area of concern. The winners will be the executives who thoroughly understand the challenges of their markets build key relationships and retain local talent. They will reap the rewards; not necessarily in the short-term but certainly on a sustainable, long-term basis. Moreover to complement this increased influx of global pharma manufacturers we have witnessed a number of encouraging initiatives from different GCC governments to encourage private sector participation in the sector; this is a very important step given that most of the pharma procurement in the region is governmental driven. For example roughly around 60% of the pharmaceuticals sold in the KSA, the largest market in the region, are procured by the Ministry of Health  said Jad Bitar, a Principal with the Healthcare practice at Booz & Company.

It is important to bear in mind however that whilst emerging markets offer huge untapped potential, they also display a wide diversity in their stages of development. The BRICMT countries are much more developed than the so-called “2nd tier emerging markets” in South-East Asia and then Africa, and there is a huge difference in size. Yet, they are all regarded as “emerging markets”. The vast majority of decision makers remain cautious about these 2nd tier markets, despite the projected growth rates in Africa of 28%.  Only 43% of pharmaceutical managers surveyed believed that the same steps being taken in the BRICMT countries were worthwhile in 2nd tier markets. Collaborations with governments or local sales representatives are currently preferred here. 'We are at a turning point where some regional manufacturers have commenced developing their capabilities and are now in a prime position to maximize their market presence and sales especially given the global economic climate as well as the pharmaceutical industry patent cliff (Several billions of branded pharmaceutical are expected to lose patency by the year 2018), I believe this is a golden opportunity which we need to maximize and make sure that we are all fit to grow and meet the expected upcoming market needs' concluded Raffi Boladian, an Associate at Booz & Company.
###


Posted by : Dubai PR Network Editorial Team
Viewed 8192 times
PR Category : Others
Posted on : Monday, April 8, 2013  3:48:00 PM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : EMIRATISATION GOES DIGITAL WITH NEW ONLINE JOB PORTAL
Next Story : Booz & Company Closes Acquisition of Management Engineers
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Boss Bottled Infinite: Express Your Inner Self [17031-Views]
Mouawad Announces New Partnership With the Miss Universe Organization [10748-Views]
Ralph Lauren Introduces Ralph's Club for New York Fashion Week [9431-Views]
Introducing the new Baby Bio Organic Range from Corine de Farme [9321-Views]
Chronoswiss adds beauty in blue to Sirius Chronograph Moon Phase collection [8473-Views]
Expect more from your concealer, why settle for less! [7027-Views]
Ncef-reverse Eyes – Filorga's New Ground Breaking Eye Care! [6881-Views]
Marks & Spencer Unveils Its Autumn 2019 Kidswear Collection'' [6496-Views]
Admiral Legend 42 Icon ahead [6417-Views]
Roberto Cavalli's exclusive new duo of fragrances [6411-Views]
UAE Welcomes Energy Industry's Thought Leaders at World's Most Influential Energy Event [6124-Views]
La Roche-posay Presents an Incomparable Skincare Experience With ‘My Skin Track UV;' the W... [6057-Views]
Tag Heuer Launches First Ever Emerald Green Dial Aquaracer (for Men & Women) in the UAE [5990-Views]
ENEC to showcase economic, social and environmental benefits of nuclear energy at World En... [5893-Views]
World's First Cartridge-Free Laser Printer Now Available in the UAE [5539-Views]
Ferrari 812 GTS: the V12 spider returns [5362-Views]
Corum Golden Bridge Round 39 for elegant lady [5087-Views]
A Journey of Belief: Caroline Leon goes the extra mile with DHL as she attempts to climb h... [5075-Views]
The Ferrari F8 Spider: the evolution of the species [5002-Views]
Sony Middle East and Africa launches the new king of full frame mirrorless cameras – Alpha... [4874-Views]
Tabreed demonstrates commitment to enhancing energy efficiency with ISO 50001 certificatio... [4801-Views]
Samsung Galaxy Fold Now Available [4734-Views]
Tissot Carson Automatic Urban vitality [4660-Views]
Trade Up Your Old Device For the Next Level Power Galaxy Note10 [4416-Views]
Lenovo Launches New Devices: Offering Smarter Technology for All [4349-Views]
 
RSS Facebook Twitter LinkedDin
 
Top Sections
 
Top Stories